Sign In
Buy STVN
$19.85
-0.350 (-1.73%)
At Close: Jul 31, 2026
Stevanato Group S.p.A. (STVN) Q4 2023 Earnings Call Transcript
02:41pm, Thursday, 07'th Mar 2024
Stevanato Group S.p.A. (NYSE:STVN ) Q4 2023 Earnings Conference Call March 7, 2024 8:30 AM ET Company Participants Lisa Miles - Senior Vice President of Investor Relations Franco Stevanato - Executive
Stevanato Group Delivers Double-Digit Revenue Growth in Fiscal Year 2023
06:30am, Thursday, 07'th Mar 2024
PIOMBINO DESE, Italy--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology,
Stevanato Group to Report Fourth Quarter and Year End 2023 Financial Results on March 7, 2024
04:30pm, Thursday, 22'nd Feb 2024
PIOMBINO DESE, Italy--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology,
Stevanato Group Launches EZ-fill® Kit and Laboratory Fill and Finish Service to Support Small Batch Drug Development and Commercialization
08:00am, Wednesday, 24'th Jan 2024
PIOMBINO DESE, Italy--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment and delivery solutions to the pharmaceutical, biotechnology, and life sciences
Stevanato Group to Present at the 42nd Annual J.P. Morgan Healthcare Conference
04:30pm, Wednesday, 03'rd Jan 2024
PIOMBINO DESE, Italy--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology,
Stevanato Group's Mavis™ Combi Visual Inspection Machine Selected as Pharma Innovation Award Winner by Pharma Manufacturing
06:00am, Thursday, 16'th Nov 2023
PIOMBINO DESE, Italy--(BUSINESS WIRE)--Stevanato Group (NYSE: STVN), a leading global provider of drug containment and delivery solutions to the pharmaceutical, biotechnology, and life science industr
Stevanato Group to Present at the Jefferies London Healthcare Conference
06:30am, Thursday, 09'th Nov 2023
PIOMBINO DESE, Italy--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology,
Stevanato Group S.p.A. (STVN) Q3 2023 Earnings Call Transcript
12:31pm, Tuesday, 31'st Oct 2023
Stevanato Group S.p.A. (STVN) Q3 2023 Earnings Call Transcript
Stevanato Group (STVN) Q3 Earnings Meet Estimates
09:01am, Tuesday, 31'st Oct 2023
Stevanato Group (STVN) came out with quarterly earnings of $0.16 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.14 per share a year ago.
TAK vs. STVN: Which Stock Is the Better Value Option?
12:47pm, Friday, 27'th Oct 2023
Investors interested in stocks from the Medical - Drugs sector have probably already heard of Takeda Pharmaceutical Co. (TAK) and Stevanato Group (STVN). But which of these two stocks presents investo
Stevanato Group to Report Third Quarter 2023 Financial Results on October 31, 2023
04:05pm, Tuesday, 17'th Oct 2023
PIOMBINO DESE, Italy--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology,
USNA or STVN: Which Is the Better Value Stock Right Now?
12:47pm, Wednesday, 11'th Oct 2023
Investors looking for stocks in the Medical - Drugs sector might want to consider either USANA Health Sciences (USNA) or Stevanato Group (STVN). But which of these two stocks is more attractive to val
Stevanato: Secular Tailwinds In Biologics Support Downstream Demand
05:21am, Friday, 15'th Sep 2023
Stevanato Group is a global provider of drug containment with a CAPEX growth plan to support growth and reach new geographical diversification. Balance sheet flexibility thanks to margin expansions. S
GRFS or STVN: Which Is the Better Value Stock Right Now?
12:46pm, Thursday, 14'th Sep 2023
Investors looking for stocks in the Medical - Drugs sector might want to consider either Grifols (GRFS) or Stevanato Group (STVN). But which of these two companies is the best option for those looking
All You Need to Know About Stevanato (STVN) Rating Upgrade to Buy
01:32pm, Monday, 11'th Sep 2023
Stevanato (STVN) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
